| MR编号 | FR/V/0287/001 |
|---|
| 药品名称 | EURCAN DAP-L3 |
|---|
| 活性成分 | - canine adenovirus 0.0 CCID50
- canine distemper virus 0.0 CCID50
- canine parvovirus 0.0 CCID50
- leptospira interrogans serogroup canicola 0.0 %
- leptospira interrogans serogroup icterohaemorragiae 0.0 %
- Leptospira kirschneri serogroup Grippotyphosa 0.0 %
|
|---|
| 剂型 | Lyophilisate and solvent for suspension for injection |
|---|
| 上市许可持有人 | MERIAL |
|---|
| 参考成员国 - 产品名称 | France (FR) EURICAN DAP L-MULTI |
|---|
| 互认成员国 - 产品名称 | - Germany (DE)
Eurican DHP-Lmulti - Belgium (BE)
Eurican DAP-Lmulti - Netherlands (NL)
- Luxembourg (LU)
- Austria (AT)
Eurican SHPLmulti, Lyophilisat und Suspension zur Herstellung einer Injektionssuspension - Spain (ES)
- Portugal (PT)
- Italy (IT)
- Greece (GR)
- Poland (PL)
- Latvia (LV)
Eurican DHP-Lmulti - Lithuania (LT)
- Hungary (HU)
Eurican DHP-L3 vakcina A.U.V. - Bulgaria (BG)
- Cyprus (CY)
- Czechia (CZ)
- Romania (RO)
- Slovakia (SK)
- Slovenia (SI)
- Malta (MT)
- Croatia (HR)
- Liechtenstein (LI)
|
|---|
| 许可日期 | 2015/07/22 |
|---|
| 最近更新日期 | 2024/07/04 |
|---|
| 药物ATC编码 | - QI07AI03 live canine distemper virus + live canine adenovirus + live canine parvovirus + inactivated leptospira
| 申请类型 | - TypeLevel1：[not specified]
- TypeLevel2：[not specified]
- TypeLevel3：Full dossier - art 12.3 Dir 2001/82/EC
- TypeLevel4：[not specified]
- TypeLevel5：[not specified]
|
|---|
| 附件文件下载 | |
|---|
| 市场状态 | Positive |
|---|
|
|---|